262 related articles for article (PubMed ID: 23560496)
1. Inverse expression of hyaluronidase 2 and hyaluronan synthases 1-3 is associated with reduced hyaluronan content in malignant cutaneous melanoma.
Siiskonen H; Poukka M; Tyynelä-Korhonen K; Sironen R; Pasonen-Seppänen S
BMC Cancer; 2013 Apr; 13():181. PubMed ID: 23560496
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of hyaluronan synthase 1 and 2 associates with poor prognosis in cutaneous melanoma.
Poukka M; Bykachev A; Siiskonen H; Tyynelä-Korhonen K; Auvinen P; Pasonen-Seppänen S; Sironen R
BMC Cancer; 2016 May; 16():313. PubMed ID: 27184066
[TBL] [Abstract][Full Text] [Related]
3. Expression of hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in serous ovarian carcinomas: inverse correlation between HYAL1 and hyaluronan content.
Nykopp TK; Rilla K; Sironen R; Tammi MI; Tammi RH; Hämäläinen K; Heikkinen AM; Komulainen M; Kosma VM; Anttila M
BMC Cancer; 2009 May; 9():143. PubMed ID: 19435493
[TBL] [Abstract][Full Text] [Related]
4. A novel role of low molecular weight hyaluronan in breast cancer metastasis.
Wu M; Cao M; He Y; Liu Y; Yang C; Du Y; Wang W; Gao F
FASEB J; 2015 Apr; 29(4):1290-8. PubMed ID: 25550464
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma.
Nykopp TK; Rilla K; Tammi MI; Tammi RH; Sironen R; Hämäläinen K; Kosma VM; Heinonen S; Anttila M
BMC Cancer; 2010 Sep; 10():512. PubMed ID: 20875124
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of hyaluronan synthase-2 reduces the tumorigenic potential of glioma cells lacking hyaluronidase activity.
Enegd B; King JA; Stylli S; Paradiso L; Kaye AH; Novak U
Neurosurgery; 2002 Jun; 50(6):1311-8. PubMed ID: 12015850
[TBL] [Abstract][Full Text] [Related]
7. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
Boyd AS; Shakhtour B; Shyr Y
J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
[TBL] [Abstract][Full Text] [Related]
8. Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions.
Miracco C; Cevenini G; Franchi A; Luzi P; Cosci E; Mourmouras V; Monciatti I; Mannucci S; Biagioli M; Toscano M; Moretti D; Lio R; Massi D
Hum Pathol; 2010 Apr; 41(4):503-12. PubMed ID: 20004946
[TBL] [Abstract][Full Text] [Related]
9. UDP-sugar substrates of HAS3 regulate its O-GlcNAcylation, intracellular traffic, extracellular shedding and correlate with melanoma progression.
Deen AJ; Arasu UT; Pasonen-Seppänen S; Hassinen A; Takabe P; Wojciechowski S; Kärnä R; Rilla K; Kellokumpu S; Tammi R; Tammi M; Oikari S
Cell Mol Life Sci; 2016 Aug; 73(16):3183-204. PubMed ID: 26883802
[TBL] [Abstract][Full Text] [Related]
10. Tumor-suppressive functions of 4-MU on breast cancer cells of different ER status: Regulation of hyaluronan/HAS2/CD44 and specific matrix effectors.
Karalis TT; Heldin P; Vynios DH; Neill T; Buraschi S; Iozzo RV; Karamanos NK; Skandalis SS
Matrix Biol; 2019 May; 78-79():118-138. PubMed ID: 29673760
[TBL] [Abstract][Full Text] [Related]
11. Moesin and CD44 expression in cutaneous melanocytic tumours.
Ichikawa T; Masumoto J; Kaneko M; Saida T; Sagara J; Taniguchi S
Br J Dermatol; 1998 May; 138(5):763-8. PubMed ID: 9666819
[TBL] [Abstract][Full Text] [Related]
12. Differential hyaluronan homeostasis and expression of proteoglycans in juvenile and adult human skin.
Tzellos TG; Sinopidis X; Kyrgidis A; Vahtsevanos K; Triaridis S; Printza A; Klagas I; Karakiulakis G; Papakonstantinou E
J Dermatol Sci; 2011 Jan; 61(1):69-72. PubMed ID: 21087840
[No Abstract] [Full Text] [Related]
13. CD44 and variants in melanocytic skin neoplasms.
Schaider H; Soyer HP; Heider KH; Hofmann-Wellenhof R; Zatloukal K; Smolle J; Kerl H
J Cutan Pathol; 1998 Apr; 25(4):199-203. PubMed ID: 9609138
[TBL] [Abstract][Full Text] [Related]
14. V3 versican isoform alters the behavior of human melanoma cells by interfering with CD44/ErbB-dependent signaling.
Hernández D; Miquel-Serra L; Docampo MJ; Marco-Ramell A; Cabrera J; Fabra A; Bassols A
J Biol Chem; 2011 Jan; 286(2):1475-85. PubMed ID: 21078678
[TBL] [Abstract][Full Text] [Related]
15. PP2B and ERK1/2 regulate hyaluronan synthesis of HT168 and WM35 human melanoma cell lines.
Katona É; Juhász T; Somogyi CS; Hajdú T; Szász C; Rácz K; Kókai E; Gergely P; Zákány R
Int J Oncol; 2016 Mar; 48(3):983-97. PubMed ID: 26717964
[TBL] [Abstract][Full Text] [Related]
16. Biomimetic tissue models reveal the role of hyaluronan in melanoma proliferation and invasion.
Sapudom J; Nguyen KT; Martin S; Wippold T; Möller S; Schnabelrauch M; Anderegg U; Pompe T
Biomater Sci; 2020 Mar; 8(5):1405-1417. PubMed ID: 31939453
[TBL] [Abstract][Full Text] [Related]
17. Nodular basal cell carcinoma is associated with increased hyaluronan homeostasis.
Tzellos TG; Kyrgidis A; Vahtsevanos K; Triaridis S; Printza A; Klagas I; Zvintzou E; Kritis A; Karakiulakis G; Papakonstantinou E
J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):679-87. PubMed ID: 20849445
[TBL] [Abstract][Full Text] [Related]
18. CD44 and melanocytic tumors: a possible role for standard CD44 in the epidermotropic spread of melanoma.
Fernández-Figueras MT; Ariza A; Calatrava A; Puig L; Fernández-Vasalo A; Ferrándiz C
J Cutan Pathol; 1996 Apr; 23(2):133-9. PubMed ID: 8721447
[TBL] [Abstract][Full Text] [Related]
19. Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma.
Fang D; Hallman J; Sangha N; Kute TE; Hammarback JA; White WL; Setaluri V
Am J Pathol; 2001 Jun; 158(6):2107-15. PubMed ID: 11395388
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of hyaluronan synthase and hyaluronidase mRNA may affect hyaluronic acid distribution in keloid disease compared with normal skin.
Sidgwick GP; Iqbal SA; Bayat A
Exp Dermatol; 2013 May; 22(5):377-9. PubMed ID: 23614752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
